← The Wire
IMVTNasdaq
Immunovant, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1764013
Developing IMVT-1402 to treat autoimmune diseases by inhibiting FcRn and reducing pathogenic IgG antibodies
$6.90B
Market cap
$38.51
Last close
-0.9%
1D
+1.1%
5D
1.3M
Volume
Price · last 39 sessions+38.3%
May 4L $26.29 · H $38.85Jun 29
157
Total filings
May 20, 2026
Last filing
03/31
Fiscal year end
SC 13GSC 13GFeb 9, 2024SC 13GSC 13GFeb 11, 2022SC 13GSC 13GOct 8, 2019SC 13GSCHEDULE 13GMay 22, 2019SC 13GSC 13GMay 20, 2019SC 13GHEALTH SCIENCES ACQUISITIONS CORPORATIONMay 20, 2019
Insider Activity
In the 90 days to Mar 18, 2026: 3 sold $536K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Van Tuyl ChristopherChief Legal Officer | Sell | 2,877 | $24.97 | $72K |
| Feb 25, 2026 | Gloria MelanieChief Operating Officer | Sell | 1,437 | $26.98 | $39K |
| Feb 25, 2026 | Gloria MelanieChief Operating Officer | Sell | 942 | $28.90 | $27K |
| Feb 25, 2026 | Gloria MelanieChief Operating Officer | Sell | 859 | $28.16 | $24K |
| Jan 21, 2026 | Stout Jay SChief Technology Officer | Sell | 1,977 | $26.03 | $51K |
| Jan 7, 2026 | Stout Jay SChief Technology Officer | Sell | 1,148 | $26.51 | $30K |
| Jan 7, 2026 | Stout Jay SChief Technology Officer | Sell | 55 | $26.92 | $1K |
| Dec 18, 2025 | Van Tuyl ChristopherChief Legal Officer | Sell | 8,529 | $26.78 | $228K |
| Dec 18, 2025 | Van Tuyl ChristopherChief Legal Officer | Sell | 2,284 | $27.38 | $63K |
| Dec 12, 2025 | Roivant Sciences Ltd.Director,TenPercentOwner | Buy | 16,666,666 | $21.00 | $350.0M |
| Dec 1, 2025 | Fromkin Andrew J.Director | Sell | 19,351 | $23.14 | $448K |
| Dec 1, 2025 | Hughes Douglas J.Director | Sell | 13,091 | $23.14 | $303K |
| Dec 1, 2025 | Fromkin Andrew J.Director | Sell | 2,898 | $23.95 | $69K |
| Dec 1, 2025 | Hughes Douglas J.Director | Sell | 1,909 | $23.96 | $46K |
| Nov 20, 2025 | Gloria MelanieChief Operating Officer | Sell | 10,251 | $23.54 | $241K |
| Nov 20, 2025 | Gloria MelanieChief Operating Officer | Sell | 2,375 | $23.97 | $57K |
| Oct 22, 2025 | Geffner MichaelChief Medical Officer | Sell | 2,595 | $19.03 | $49K |
| Oct 22, 2025 | Stout Jay SChief Technology Officer | Sell | 2,520 | $19.03 | $48K |
| Oct 8, 2025 | Stout Jay SChief Technology Officer | Sell | 1,585 | $16.30 | $26K |
| Oct 8, 2025 | Geffner MichaelChief Medical Officer | Sell | 1,272 | $16.30 | $21K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Barron's2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug1mo agoBarron'sNvidia, Astera Labs, Micron, Intel, United, Hasbro, Toll, Immunovant, Analog Devices, and More Movers1mo agoInvestor's Business DailyThese Two Biotech Stocks Rocketed — And One Just Broke Out1mo ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance